Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study

Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study

High hepcidin is linked to low-grade inflammation and lower iron levels. The consequences of testosterone replacement therapy (TRT) on inflammation and the risk of cardiovascular disease (CVD) are undetermined. We investigate the effect of TRT on the inflammatory cardiovascular risk markers hepcidin...

Full description

Bibliographic Details
Main Authors: Line Velling Magnussen, Louise Helskov Jørgensen, Dorte Glintborg, Marianne Skovsager Andersen
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomedicines
Subjects:
testosterone therapy
cardiovascular disease markers
type 2 diabetes mellitus
Online Access:https://www.mdpi.com/2227-9059/11/12/3184

Similar Items

Similar Items